Apar Kishor Ganti

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. ncbi request reprint Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia
    Apar Kishor Ganti
    Section of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA
    In Vivo 20:559-63. 2006
  2. pmc Pancytopenia due to iron deficiency worsened by iron infusion: a case report
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    J Med Case Reports 1:175. 2007
  3. doi request reprint Association between race and survival of patients with non-small-cell lung cancer in the United States veterans affairs population
    Apar Kishor Ganti
    Department of Internal Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE Electronic address
    Clin Lung Cancer 15:152-8. 2014
  4. pmc Current concepts in the management of small cell lung cancer
    Apar Kishor Ganti
    Section of Hematology Oncology, Department of Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE 68198 7680, USA
    Indian J Med Res 137:1043-51. 2013
  5. doi request reprint Predictive ability of Charlson comorbidity index on outcomes from lung cancer
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha
    Am J Clin Oncol 34:593-6. 2011
  6. ncbi request reprint Treatment of non-small cell lung cancer in the older patient
    Apar Kishor Ganti
    Department of Internal Medicine, Omaha VA Medical Center, Omaha, Nebraska, USA
    J Natl Compr Canc Netw 10:230-9. 2012
  7. ncbi request reprint Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning
    Apar Kishor Ganti
    University of Nebraska Medical Center, Section of Oncology Hematology, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 25:5643-8. 2007
  8. ncbi request reprint Epidermal growth factor inhibition in solid tumours
    Apar Kishor Ganti
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Expert Opin Biol Ther 5:1165-74. 2005
  9. ncbi request reprint Hormone replacement therapy is associated with decreased survival in women with lung cancer
    Apar Kishor Ganti
    Section of Hematology Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 24:59-63. 2006
  10. ncbi request reprint Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis
    Apar Kishor Ganti
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Thromb Thrombolysis 23:155-8. 2007

Collaborators

Detail Information

Publications52

  1. ncbi request reprint Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia
    Apar Kishor Ganti
    Section of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA
    In Vivo 20:559-63. 2006
    ..The aim of the present study was to assess the efficacy of vincristine-laden platelet transfusion for patients with refractory thrombocytopenia...
  2. pmc Pancytopenia due to iron deficiency worsened by iron infusion: a case report
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE, USA
    J Med Case Reports 1:175. 2007
    ..Much less common is the development of thrombocytopenia following replenishment of iron stores...
  3. doi request reprint Association between race and survival of patients with non-small-cell lung cancer in the United States veterans affairs population
    Apar Kishor Ganti
    Department of Internal Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE Electronic address
    Clin Lung Cancer 15:152-8. 2014
    ..A retrospective analysis of patients in the Veterans Affairs Central Cancer Registry was conducted to determine whether similar disparities exist in a population with a single-payer, accessible health care system...
  4. pmc Current concepts in the management of small cell lung cancer
    Apar Kishor Ganti
    Section of Hematology Oncology, Department of Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE 68198 7680, USA
    Indian J Med Res 137:1043-51. 2013
    ..Newer targeted agents are currently being evaluated for this disease. ..
  5. doi request reprint Predictive ability of Charlson comorbidity index on outcomes from lung cancer
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha
    Am J Clin Oncol 34:593-6. 2011
    ..The Charlson Comorbidity Index (CCI) was developed to help predict mortality from chronic medical conditions. This study was undertaken to evaluate whether CCI is correlated with survival in lung cancer...
  6. ncbi request reprint Treatment of non-small cell lung cancer in the older patient
    Apar Kishor Ganti
    Department of Internal Medicine, Omaha VA Medical Center, Omaha, Nebraska, USA
    J Natl Compr Canc Netw 10:230-9. 2012
    ..If an older patient is deemed to be fit, it is reasonable to use the treatment options recommended for younger individuals. This article summarizes the available data on the treatment of non-small cell lung cancer in the older patient...
  7. ncbi request reprint Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning
    Apar Kishor Ganti
    University of Nebraska Medical Center, Section of Oncology Hematology, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 25:5643-8. 2007
    ..We conducted this analysis to determine if engagement in ACP among patients who undergo HSCT is associated with adverse outcomes...
  8. ncbi request reprint Epidermal growth factor inhibition in solid tumours
    Apar Kishor Ganti
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Expert Opin Biol Ther 5:1165-74. 2005
    ..Efficacy data for these agents in various human malignancies is presented. Various other agents that are in the early stages of development at present have also been mentioned...
  9. ncbi request reprint Hormone replacement therapy is associated with decreased survival in women with lung cancer
    Apar Kishor Ganti
    Section of Hematology Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Clin Oncol 24:59-63. 2006
    ..Hence, we conducted a retrospective study to examine the impact of HRT on the natural history of lung cancer...
  10. ncbi request reprint Hematopoietic stem cell transplantation for Hodgkin's disease in a patient with dysfibrinogenemia and thrombosis
    Apar Kishor Ganti
    Department of Internal Medicine, Section of Oncology Hematology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198 7680, USA
    J Thromb Thrombolysis 23:155-8. 2007
    ..Management of patients with dysfibrinogenemia and a thrombotic tendency usually involves long-term anticoagulation...
  11. ncbi request reprint Lung cancer screening
    Apar Kishor Ganti
    Division of Hematology Oncology, Department of Internal Medicine, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Oncologist 11:481-7. 2006
    ..Currently, the decision to screen for lung cancer should involve a careful discussion with the individuals involved about the potential advantages, costs, and drawbacks of the approach...
  12. ncbi request reprint Limited-stage small-cell lung cancer: therapeutic options
    Apar Kishor Ganti
    Department of Internal Medicine, University of Nebraska Medical Center 68198 7680, USA
    Oncology (Williston Park) 21:303-12; discussion 312, 315-8, 323. 2007
    ..Newer targeted agents are currently being evaluated in this disease and hold the promise of improving current outcomes seen in patients with early-stage disease...
  13. ncbi request reprint Follicular lymphoma: expanding therapeutic options
    Apar Kishor Ganti
    Department of Internal Medicine, University of Nebraska, Omaha, Nebraska, USA
    Oncology (Williston Park) 19:213-28; discussion 228, 233-6, 239. 2005
    ..Future directions in the treatment of follicular lymphoma include vaccines, antisense therapy, and proteasome inhibitors...
  14. ncbi request reprint Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer
    Apar Kishor Ganti
    Department of Internal Medicine, Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Anticancer Res 30:1365-9. 2010
    ..Limited data exist regarding specific factors that affect blood count nadirs following chemotherapy...
  15. doi request reprint Association of positive family history with survival of patients with lung cancer
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Lung Cancer 63:136-9. 2009
    ..Risk factors for development of lung cancer include a family history of the disease. The effect of family history on lung cancer outcomes is unknown. A study was conducted to investigate this...
  16. ncbi request reprint Current concepts in the diagnosis and management of small-cell lung cancer
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Oncology (Williston Park) 24:1034-9. 2010
    ..While the frontline treatment of SCLC has not changed significantly in the past decade, newer agents that are currently being investigated provide hope for better treatment of relapsed/refractory disease for the future...
  17. doi request reprint Epidermal growth factor receptor signaling in nonsmall cell lung cancer
    Apar Kishor Ganti
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, 68198 7680, USA
    Cancer Invest 28:515-25. 2010
    ..Although women, nonsmokers, patients with adenocarcinoma and patients with Asian ethnicity seem to have better outcomes with erlotinib, the factors predictive for response to these agents are currently the focus of investigation...
  18. ncbi request reprint Lung cancer management in 2010
    Apar Kishor Ganti
    VA Nebraska Western Iowa Health Care System, Omaha, Nebraska, USA
    Oncology (Williston Park) 25:64-73. 2011
    ..This review summarizes important recent clinical advances that could have a significant impact on the future care of patients with lung cancer...
  19. doi request reprint Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, USA
    Cancer Treat Rev 37:440-3. 2011
    ..g. inhibitors of the hedgehog and the epidermal growth factor receptor pathways) that are currently being investigated in this disease. This review summarizes the available data on the epidemiology and management of disseminated BCC...
  20. ncbi request reprint Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas
    Anil Potti
    Department of Medicine, University of North Dakota School of Medicine, Fargo, ND 58102, USA
    Anticancer Res 24:333-7. 2004
    ....
  21. ncbi request reprint Effect of pesticide exposure on HER-2/neu overexpression seen in patients with extensive stage small cell lung carcinoma
    Anil Potti
    Department of Medicine, University of North Dakota School of Medicine, Fargo, North Dakota 58102, USA
    Clin Cancer Res 9:4872-6. 2003
    ..The aim of this study was to evaluate the relationship, if any, between pesticide exposure and overexpression of the HER-2/neu oncoprotein in extensive stage small cell lung cancer (ESSCLC)...
  22. doi request reprint Therapeutic options for elderly patients with advanced non-small cell lung cancer
    Eric J Avery
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 2055, USA
    Cancer Treat Rev 35:340-4. 2009
    ..New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer...
  23. ncbi request reprint Clinical course of lung cancer in patients with chronic kidney disease
    Purvi Patel
    Department of Internal Medicine, University of North Dakota, School of Medicine, Fargo, ND 58102, USA
    Lung Cancer 43:297-300. 2004
    ..Hence though treatment of lung cancer does need to be individualized in the setting of CKD, it should not dissuade the clinician from treating the malignancy...
  24. doi request reprint Cetuximab in hemodialysis: a case report
    Ibrahim T Aldoss
    Department of Internal Medicine, Creighton University Medical Center, Omaha, Nebraska, USA
    Head Neck 31:1647-50. 2009
    ..Concurrent chemoradiation with cetuximab has been approved in definitive treatment of locally advanced head and neck cancer. Although cetuximab is not excreted via the kidneys, its use in patients on hemodialysis has not been reported...
  25. ncbi request reprint Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer
    Nicole Annette Shonka
    Department of Internal Medicine, Section of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Med Oncol 23:515-9. 2006
    ..To assess the effect of diabetes mellitus (DM) on the pathogenesis and outcomes from colon cancer...
  26. ncbi request reprint Survival in untreated early stage non-small cell lung cancer
    Amandeep S Chadha
    Department of Internal Medicine, University of North Dakota School of Medicine, Fargo, ND 58102, USA
    Anticancer Res 25:3517-20. 2005
    ..The aim of this study was to determine the survival of untreated stage I and II in non-small cell lung cancer (NSCLC) patients...
  27. doi request reprint Pathobiological implications of MUC4 in non-small-cell lung cancer
    Prabin Dhangada Majhi
    Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA
    J Thorac Oncol 8:398-407. 2013
    ..Altered expression of MUC4 plays an oncogenic role in various cancers, including pancreatic, ovarian, and breast. This study evaluates the expression and role of MUC4 in non-small-cell lung cancer (NSCLC)...
  28. ncbi request reprint Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome
    Apar Kishor Ganti
    Department of Internal Medicine, Division of Oncology Hematology, University of Nebraska Medical Center, Omaha, Nebraska 68198 7680, USA
    Am J Hematol 79:206-10. 2005
    ..He is currently ambulatory and does not need wheelchair assistance. Hematopoietic stem-cell transplantation may be a treatment option for patients with multicentric Castleman disease and POEMS syndrome...
  29. ncbi request reprint HER-2/neu and CD117 (C-kit) overexpression in hepatocellular and pancreatic carcinoma
    Anil Potti
    Department of Medicine, University of North Dakota School of Medicine, Fargo, ND 58102, USA
    Anticancer Res 23:2671-4. 2003
    ..99. The aim of this study was to determine the prevalence of HER-2/neu and c-kit (CD117) overexpression and to identify a possible predictive role in patients with these two malignancies...
  30. ncbi request reprint Angiosarcoma of the small intestine: a possible role for thalidomide?
    Genise Fraiman
    Department of Internal Medicine, Veterans Affairs Medical Center, Fargo, ND 58102, USA
    Med Oncol 20:397-402. 2003
    ..At that time he was found to have hepatic metastases. He was started on thalidomide as an experimental measure with no change in the performance status and increasing evidence of necrosis in the metastatic lesion...
  31. ncbi request reprint Predictive value of absent bone marrow iron stores in the clinical diagnosis of iron deficiency anemia
    Apar Kishor Ganti
    Department of Internal Medicine, University of North Dakota School of Medicine, 1919 Elm Street N, Fargo, ND 58102, USA
    In Vivo 17:389-92. 2003
    ..The finding of absent stores of iron in the bone marrow needs to be taken in conjunction with other laboratory findings and the clinical scenario while making a diagnosis of IDA, since certain other hematological diseases may co-exist...
  32. doi request reprint Seliciclib in malignancies
    Ibrahim T Aldoss
    Creighton University Medical Center, Department of Internal Medicine, Omaha, NE, USA
    Expert Opin Investig Drugs 18:1957-65. 2009
    ..At present, it is in Phase II trials for non-small cell lung cancer and nasopharyngeal carcinoma...
  33. doi request reprint Targeted anti-cancer therapy in the elderly
    Wilson Gonsalves
    Department of Internal Medicine, Creighton University Medical Center, Omaha, NE, United States
    Crit Rev Oncol Hematol 78:227-42. 2011
    ..This article reviews the current literature on the efficacy, cost-effectiveness and toxicity of the currently approved targeted agents in the elderly population...
  34. pmc Lung cancer in women: role of estrogens
    Subhankar Chakraborty
    Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198 7680, USA
    Expert Rev Respir Med 4:509-18. 2010
    ..Laboratory evidence lends credence to the carcinogenic effects of estrogens in lung cancer. This article summarizes the current evidence on their role in lung cancer...
  35. ncbi request reprint Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma
    Anil Potti
    Department of Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, ND 58102, USA
    Anticancer Res 22:2899-901. 2002
    ..We evaluated the incidence of c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in patients with MCL in an effort to identify possible targets for therapeutic intervention...
  36. ncbi request reprint Role of infections in atherogenesis
    Sandeep T Laroia
    Department of Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo 58102, USA
    Indian Heart J 55:27-34. 2003
  37. ncbi request reprint Chromosomal anomalies in two coexistent myeloproliferative disorders
    Apar Kishor Ganti
    Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, ND 58102, USA
    Cancer Genet Cytogenet 145:172-5. 2003
    ..This also raises an interesting therapeutic consideration of using concomitant imatinib mesylate and hydroxyurea...
  38. ncbi request reprint Targeted therapy for squamous cell carcinoma of the head and neck
    Ibrahim T Aldoss
    The Department of Internal Medicine, Creighton University Medical Center, Omaha, NE, USA
    J Egypt Natl Canc Inst 21:157-66. 2009
    ..Hence these receptors and their downstream pathways make attractive therapeutic targets. This review discusses targeted therapies currently being evaluated for their role in squamous cell carcinoma of the head and neck...
  39. ncbi request reprint Uncommon syndromes and treatment manifestations of malignancy: Case 2. Metastatic non-small-cell lung cancer presenting with leukocytosis
    Apar Kishor Ganti
    Department of Internal Medicine, University of North Dakota School of Medicine, USA
    J Clin Oncol 21:168-70. 2003
  40. ncbi request reprint Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases
    Apar Kishor Ganti
    Department of Internal Medicine, University of North Dakota, School of Medicine, Fargo, ND 58102, USA
    Med Oncol 19:233-7. 2002
    ..Pancreatic adenocarcinoma is a disease of the elderly associated with a poorer outcome. Knowledge of possible clinical predictors of survival may lead to better patient counseling regarding prognosis...
  41. doi request reprint Human papilloma virus positive oropharyngeal squamous cell carcinoma: a growing epidemic
    Aru Panwar
    Division of Head and Neck Surgery, University of Nebraska Medical Center, Omaha, NE, USA
    Cancer Treat Rev 40:215-9. 2014
    ..This review focuses on the pathogenesis of HPV mediated OPSCC and details the current evidence in the management of these patients...
  42. doi request reprint Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis
    K M Monirul Islam
    Department of Epidemiology, University of Nebraska Medical Center, Omaha, NE, United States
    Lung Cancer 82:90-4. 2013
    ..Whether this is due to selection of healthier patients for surgery is unclear. This study was undertaken to compare outcomes between surgical patients and patients who were surgical candidates but did not receive surgery...
  43. doi request reprint Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature
    Jairam Krishnamurthy
    Division of Oncology Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska
    Head Neck 35:E372-5. 2013
    ..Salivary duct carcinoma (SDC) is a rare malignancy with a poor prognosis. Human epidermal growth factor receptor-2 (Her-2/neu) is overexpressed in SDC and, hence, HER-2/neu targeted therapy could be an option...
  44. ncbi request reprint Endothelium and the lipid metabolism: the current understanding
    Sandeep T Laroia
    Department of Medicine, School of Medicine and Health Sciences, University of North Dakota, Fargo, ND 58102, USA
    Int J Cardiol 88:1-9. 2003
    ..Clinical trials are underway examining the role of endothelin-1 receptor antagonists like bosentan in the prevention of graft atherosclerosis...
  45. doi request reprint Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels
    Ramya Thota
    Internal Medicine Resident PGY3, Creighton University, 601 N 30th Street, Omaha, NE 68131, USA
    J Thromb Thrombolysis 34:132-4. 2012
    ..We hereby report an unusual case of heparin resistance due to increased factor VIII levels in an elderly male with infective endocarditis...
  46. doi request reprint Pulmonary toxicities from targeted therapies: a review
    Nicholas A Barber
    Division of Hematology Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA
    Target Oncol 6:235-43. 2011
    ..Discerning these pulmonary adverse effects may help in making decisions on diagnostic testing and therapy, particularly for those with pulmonary and cardiovascular co-morbidities...
  47. ncbi request reprint Myeloproliferative syndromes and the associated risk of coronary artery disease
    Apar Kishor Ganti
    Department of Internal Medicine, University of North Dakota School of Medicine, 1919 Elm Street N, Fargo, ND 58102, USA
    Thromb Res 110:83-6. 2003
    ..However, the relationship between these myeloproliferative syndromes and coronary artery disease (CAD) is unclear...
  48. ncbi request reprint Targeted therapy in advanced non-small cell lung cancer (NSCLC): where do we stand?
    Hatem A Azim
    Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
    Cancer Treat Rev 32:630-6. 2006
    ..This review will briefly discuss the important trials using these targeted agents in advanced NSCLC...
  49. ncbi request reprint Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future
    Anil Potti
    Duke Institute for Genome Sciences and Policy, Division of Hematology, Duke University Medical Center, Box 3382, CIEMAS, Durham, NC 27710, USA
    Expert Opin Biol Ther 6:709-16. 2006
    ..The role of targeted agents in this setting is being investigated. Gene expression profiling studies should help direct chemotherapy to those who would actually benefit from it, thereby saving others from unnecessary toxicity...
  50. ncbi request reprint Treatment options for relapsed small-cell lung cancer
    Hatem A Azim
    Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt
    Anticancer Drugs 18:255-61. 2007
    ..This review focuses on the various current and future options, including cytoxic and targeted agents, for salvage therapy in patients with this disease...
  51. ncbi request reprint Comparison of resource utilization and clinical outcomes between teaching and nonteaching medical services
    Amir A Khaliq
    Department of Health Administration and Policy, University of Oklahoma Health Sciences Center, College of Public Health, Oklahoma City, OK 73104, USA
    J Hosp Med 2:150-7. 2007
    ..To compare the resource utilization and clinical outcomes of medical care delivered on general internal medicine inpatient services at teaching and nonteaching services at an academic hospital...
  52. ncbi request reprint HER-2/neu overexpression detected by immunohistochemistry in soft tissue sarcomas
    Heidi Foster
    Department of Medicine, University of North Dakota School of Medicine, Fargo, ND 58102, U S A
    Am J Clin Oncol 26:188-91. 2003
    ..In addition, there may be a role for Herceptin (trastuzumab) alone, or in combination with conventional therapy, in patients with CS, MHF, and DFS...